B2M and amyloidosis: The main recognized manifestation of β2M accumulation in patients receiving long-term dialysis is dialysis-related amyloidosis [18–22], but more recently β2M has also been linked to higher mortality in hemodialysis (HD) patients [14,23,24], to aortic calcification and cardiovascular mortality in patients with non-dialysis dependent CKD [25].